Replicate study designs are now essential for assessing bioequivalence of highly variable drugs. They reduce sample sizes by up to 75%, enable regulatory-compliant scaling, and are required for drugs like warfarin and levothyroxine. Learn how to choose the right design and avoid common pitfalls.
Continue ReadingClinical outcomes data shows generic medications are just as effective and safe as brand-name drugs for nearly all conditions. Providers can confidently prescribe generics, backed by decades of research and real-world evidence.
Continue ReadingPharmacists must counsel patients on generic medications to address misconceptions, ensure adherence, and prevent dangerous treatment interruptions. Learn the essential topics to cover and how to do it effectively.
Continue Reading